Patient Status at ICU Discharge, Not Timing, Predicts Survival

This article originally appeared here.
Share this content:
Patient Status at ICU Discharge, Not Timing, Predicts Survival
Patient Status at ICU Discharge, Not Timing, Predicts Survival

THURSDAY, March 19, 2015 (HealthDay News) -- For patients discharged from the intensive care unit (ICU), patient status, particularly the presence of limitations of medical therapy (LOMT) orders, strongly predicts mortality, according to a study published online March 2 in the American Journal of Respiratory and Critical Care Medicine.

John D. Santamaria, M.D., from St. Vincent's Hospital in Melbourne, Australia, and colleagues conducted a prospective multicenter observational study in 40 ICUs in Australia and New Zealand to examine the factors associated with mortality after ICU discharge. Data were included from 10,211 consecutive adult patients discharged alive from ICUs between September 2009 and February 2010.

The researchers found that 83.6 percent of patients were discharged in-hours and 16.4 percent were discharged after-hours; of these, 4.8 and 7.4 percent, respectively, subsequently died in the hospital. The time of discharge was no longer a significant predictor of mortality after risk adjustment for markers of illness severity at time of ICU discharge, including LOMT orders. The strongest predictor of death was the presence of an LOMT order (odds ratio, 35.4).

"In this prospective multicenter, binational observational study, we found that patient status at ICU discharge, particularly the presence of LOMT orders, was the chief predictor of hospital survival," the authors write. "In contrast to previous studies, the timing of discharge did not have an independent association with mortality."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »